1-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole D3

1-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole D3 is a chemical compound that belongs to the group of heterocyclic organic compounds. It is an isotopically-labelled derivative of 1-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole, which is a potent inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4). DPP-4 is an enzyme that is responsible for the degradation of incretin hormones, which stimulate insulin secretion and regulate glucose homeostasis. Inhibition of DPP-4 leads to increased levels of these hormones and improved glucose control in patients with type 2 diabetes. 1-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole D3 is used in research studies to determine the pharmacokinetics and metabolism of the parent compound in vivo. It is also used in drug discovery studies to evaluate the potency and selectivity of new DPP-4 inhibitors. The isotopic labelling of the compound allows for accurate quantification of the compound in biological samples using mass spectrometry. The chemical formula of 1-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole D3 is C12H13D3N4O3, and its molecular weight is 269.3 g/mol. The compound has a melting point of approximately 230-234°C and a solubility of 5mg/mL in DMSO. Its chemical structure contains a substituted imidazole ring, a lactone ring, and an unsaturated alkene. Overall, the availability of 1-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole D3 has facilitated research on the mechanism of DPP-4 inhibition and the development of new therapies for type 2 diabetes.